Skip to content
OpenCapital
Get started

GT Biopharma GTBP Q4 2024 Annual earnings

Reported February 21, 2025 · Before market open

EPS-$1.66Miss by $0.11
EPS estimate-$1.55

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.08

Versus estimates

Diluted EPS

Q1 2026-$0.11Miss by $0.03Q4 2025-$2.22Miss by $2.00Q3 2025-$0.83Miss by $0.45Q2 2025-$0.55Beat by $0.13Q1 2025-$0.76Miss by $0.12
Q4 2024-$1.66Miss by $0.11

Ask the moment GT Biopharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did GT Biopharma report Q4 2024 earnings?
GT Biopharma (GTBP) reported Q4 2024 earnings on February 21, 2025 before market open.
What were GT Biopharma's Q4 2024 revenue and EPS?
GT Biopharma reported eps of $-1.66 for Q4 2024.
Did GT Biopharma beat estimates in Q4 2024?
EPS missed the consensus estimate of $-1.55 by $0.11.
Where can I find GT Biopharma's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001493152-25-007908) directly on SEC EDGAR. The filing index links above go to sec.gov.